ArticleThe Journal of dermatology2026

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study.

Ken Horisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.